AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
More than 50 years after its debut, Israel's Kfir fighter jet gets a new lease on life
2
How Israel’s AI surveillance breakthrough in Iran is reshaping global intelligence
3
Echo: “Employees have become very good at identifying performative culture”
4
Rylo raises $85 million at $500 million valuation, targets $1 billion revenue by 2028
5
Former Microsoft and Tesla security leaders emerge with $35 million for Pi
More news

Prostate Cancer

1 stories about Prostate Cancer
Itay Barnea BioProtect

Is it time to reconsider PSA tests for Prostate Cancer?

01.09.22|Itay Barnea
“The treating physician should determine what is best for the patient based on his unique age, family history, health, lifestyle, race, ethnic background, and other factors,” writes Itay Barnea, CEO of BioProtect